Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
The Canada-India International Malaria Consortium met in MaRS last week to develop preclinical and clinical strategies for new malaria drug development.
Concerns of widespread resistance to treatment are increasing as parasite resistance to antimalarials has been documented in three of the five malaria species known to affect humans. This resistance results in a delayed or incomplete clearance of parasites from the patient's blood when the person is being treated.
As the threat of antimalarial drug resistance grows, there is increasing pressure to develop alternative treatments as well as put in place preventative measures such as bednets.
Malaria is present in more than 100 countries. It is the single largest cause of death for children under five in sub-Saharan Africa, where it kills nearly one child every minute, or more than a 1,000 children every day.
The public and private partners in this collaboration include Toronto General Research Institute, University Health Network as the Canadian lead institute (Principal Investigator: Dr. Lakshmi P. Kotra), Therapure Biopharma, Nucro-Technics, CIDAVA Innovations, International Center for Genetic Engineering and Biotechnology as the Indian lead institute (Principal Investigator: Dr. Asif Mohmmed), Lifecare Innovations-India and Birla Institute of Tech&Science-India.
With funding from Government of Canada, Government of Ontario and Government of India, this consortium has been working on a number of drug targets to develop new chemical classes of drugs that are able to overcome drug resistance to provide improved global solutions for malaria therapy